Sugi Predict

Sugi Predict / Compounds / SCHEMBL17144366

SCHEMBL17144366

SCHEMBL17144366

O=c1oc2ccccc2cc1N1CCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.55
▸ MAOA P21397 1/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ TYR P14679 1/20 0.50
▸ DAO P14920 1/20 0.50
▸ AKR1B1 P15121 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ ALDH1A1 P00352 4/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ MAPT P10636 4/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ PRKDC P78527 1/20 0.49
▸ RAB9A P51151 3/20 0.47
▸ MAOB P27338 2/20 0.47
▸ LMNA P02545 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5867498 0.95 MAOA (0.56) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL722215 0.87 BACE1 (0.55) HSD17B10MAOASMN1; SMN2POLBTYR
Hydrochloric Acid SCHEMBL15066499 0.86 BACE1 (0.54) HSD17B10MAOASMN1; SMN2POLBTYR
Hydrochloric Acid SCHEMBL5501060 0.84 BACE1 (0.53) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL15066938 0.77 ALDH1A1 (0.43) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL15068505 0.77 ALDH1A1 (0.43) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL29044069 0.77 HPGD (0.50) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL15068455 0.76 MAOA (0.50) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL15068474 0.76 HPGD (0.43) HSD17B10MAOASMN1; SMN2POLBTYR
SCHEMBL15068569 0.76 KDM4E (0.43) HSD17B10MAOASMN1; SMN2POLBTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052169-A1 Deuterated Fluorophores HOWARD HUGHES MEDICAL INSTITUTE (US) 2024-02-15 — — US disclosed
US-11787946-B2 Deuterated fluorophores HOWARD HUGHES MEDICAL INSTITUTE (US) 2023-10-17 — — US disclosed
US-20210347994-A1 DEUTERATED FLUOROPHORES HOWARD HUGHES MEDICAL INSTITUTE (US) 2021-11-11 — — US disclosed
US-11091643-B2 Deuterated fluorophores HOWARD HUGHES MEDICAL INSTITUTE (US) 2021-08-17 — — US disclosed
EP-3801495-A1 DEUTERATED FLUOROPHORES Howard Hughes Medical Institute (US) 2021-04-14 — — EP disclosed
CN-106471067-B Azetidine substituted fluorescent compounds 霍华德休斯医学研究所 2020-12-08 — — CN disclosed
EP-3126451-B1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS HUGHES HOWARD MED INST (US) 2020-09-09 — — EP disclosed
US-20190107534-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS HOWARD HUGHES MEDICAL INSTITUTE 2019-04-11 — — US disclosed
US-10161932-B2 Azetidine-substituted fluorescent compounds HOWARD HUGHES MEDICAL INSTITUTE (US) 2018-12-25 — — US disclosed
US-20180284105-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS HOWARD HUGHES MEDICAL INSTITUTE 2018-10-04 — — US disclosed
US-10018624-B1 Azetidine-substituted fluorescent compounds HOWARD HUGHES MEDICAL INSTITUTE (US) 2018-07-10 — — US disclosed
US-20180172677-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS HOWARD HUGHES MEDICAL INSTITUTE 2018-06-21 — — US disclosed
US-9933417-B2 Azetidine-substituted fluorescent compounds HOWARD HUGHES MEDICAL INSTITUTE (US) 2018-04-03 — — US disclosed
CN-106471067-A The fluorescent chemicalses that azetidine replaces 霍华德休斯医学研究所 2017-03-01 — — CN disclosed
US-20170045501-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS HOWARD HUGHES MEDICAL INSTITUTE 2017-02-16 — — US disclosed
EP-3126451-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS Howard Hughes Medical Institute (US) 2017-02-08 — — EP disclosed
WO-2015153813-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS HOWARD HUGHES MEDICAL INSTITUTE (US) 2015-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240052169-A1 Deuterated Fluorophores HDHD5, DRD4, ARF4 HSD17B10 1072/4885MAOA 720/4885SMN1; SMN2 3977/4885
US-20180284105-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS AANAT, HNMT, CHAT HSD17B10 3351/4885MAOA 30/4885SMN1; SMN2 1465/4885
US-20210347994-A1 DEUTERATED FLUOROPHORES HDHD5, DRD4, ARF4 HSD17B10 1072/4885MAOA 720/4885SMN1; SMN2 3977/4885
US-10018624-B1 Azetidine-substituted fluorescent compounds AANAT, HNMT, CHAT HSD17B10 3351/4885MAOA 30/4885SMN1; SMN2 1465/4885
US-20170045501-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS AANAT, HNMT, CHAT HSD17B10 3351/4885MAOA 30/4885SMN1; SMN2 1465/4885
US-20180172677-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS AANAT, HNMT, CHAT HSD17B10 3351/4885MAOA 30/4885SMN1; SMN2 1465/4885
US-20190107534-A1 AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS AANAT, HNMT, CHAT HSD17B10 3351/4885MAOA 30/4885SMN1; SMN2 1465/4885
US-11091643-B2 Deuterated fluorophores HDHD5, DRD4, ARF4 HSD17B10 1072/4885MAOA 720/4885SMN1; SMN2 3977/4885
US-10161932-B2 Azetidine-substituted fluorescent compounds AANAT, HNMT, CHAT HSD17B10 3351/4885MAOA 30/4885SMN1; SMN2 1465/4885
US-11787946-B2 Deuterated fluorophores HDHD5, DRD4, ARF4 HSD17B10 1072/4885MAOA 720/4885SMN1; SMN2 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.